Treatment of angina
Pro Research Analysisby 
Searched over 200M research papers
Overview of Angina Treatment Strategies
Angina, a common symptom of ischemic heart disease, is managed through a combination of pharmacological therapy, lifestyle changes, and, in some cases, revascularization procedures. The primary goals are to relieve symptoms, improve quality of life, and reduce cardiovascular risk Balla2018Kloner2017Rinaldi2025+1 MORE.
Pharmacological Therapy for Angina: First-Line and Second-Line Drugs
Current clinical guidelines recommend starting with antianginal medications to control symptoms before considering invasive procedures. Drugs are typically classified as first-line (beta-blockers, calcium channel blockers, and short-acting nitrates) and second-line (ivabradine, nicorandil, ranolazine, trimetazidine, and long-acting nitrates) treatments Balla2018Jones2013Ferrari2018+4 MORE.
First-line drugs are usually prescribed initially, but if patients cannot tolerate them, have contraindications, or remain symptomatic, second-line agents are considered. However, evidence shows that all antianginal drugs have similar efficacy in reducing symptoms, and no single drug has been proven superior in improving survival or exercise capacity Ferrari2018Ferrari2018. The distinction between first- and second-line drugs is based more on tradition than on strong evidence Balla2018Ferrari2018Ferrari2019+1 MORE.
Individualized and Patient-Centered Approaches
Recent research emphasizes the importance of tailoring angina treatment to individual patient characteristics, including comorbidities, underlying pathophysiology, and patient preferences Rinaldi2025Ferrari2018Manolis2016. For example, patients with non-obstructive coronary artery disease (ANOCA/INOCA) may benefit from more precise classification and personalized therapy . Double or triple therapy is often needed to control symptoms, and the choice of drugs should consider the patient's overall cardiovascular profile Ferrari2018Manolis2016.
Role of Revascularization and Non-Pharmacological Therapies
Coronary revascularization (such as percutaneous coronary intervention or bypass surgery) is reserved for select high-risk patients or those who do not respond to medical therapy. However, many patients experience recurrent angina even after these procedures, highlighting the need for ongoing pharmacological management Kloner2017Rinaldi2025Ferrari2019. For refractory angina not amenable to standard treatments, options like enhanced external counterpulsation, transmyocardial revascularization, and even stem cell therapy are being explored Kloner2017Rinaldi2025.
Lifestyle Modifications and Emerging Therapies
Lifestyle interventions—such as smoking cessation, weight management, adherence to a Mediterranean diet, and structured exercise programs—are essential for improving cardiovascular outcomes and quality of life in angina patients . Cardiac rehabilitation and exercise therapy have demonstrated benefits in enhancing functional capacity and reducing adverse events .
Emerging therapies, including novel pharmacological agents and interventional approaches like the coronary sinus reducer, are under investigation for patients with refractory or complex angina Rinaldi2025Husted2015. Additionally, alternative treatments such as acupuncture have shown some potential benefits in regulating the autonomic nervous system and improving cardiac function, though more research is needed .
Conclusion
The treatment of angina requires a comprehensive, individualized approach that combines pharmacological therapy, lifestyle changes, and, when necessary, revascularization. All major antianginal drugs are similarly effective in symptom control, and therapy should be tailored to each patient's needs and comorbidities. Ongoing research and emerging therapies continue to expand options for patients with refractory or complex angina, aiming to further improve outcomes and quality of life Balla2018Kloner2017Jones2013+7 MORE.
Sources and full results
Most relevant research papers on this topic